4183. Misbranding of dextroamphetamine sulfate tablets and pentobarbital
sodium capsules. U. S. v. Paul B. Ginther (Central Drug Co.). Plea
of guilty. Fine of $625, plus costs. (F. D. 0. No. 35101. Sample Nos.
48446-L, 48457-L to 48460-L, incl.)
INFORMATION FILED : August 19, 1953, Southern District of Iowa, against Paul
B. Ginther, trading as the Central Drug Co., Clinton, Iowa.
NATURE OF CHARGE : On or about October 20 and November 14 and 15, 1952,
while a number of dextroamphetamine sulfate tablets and pentobarbital
sodium capsules were being held for sale at the Central Drug Co., after ship-
ment in interstate commerce, the defendant caused various quantities of the
drugs to be dispensed without a prescription from a practitioner licensed by
law to administer such drugs. This act of dispensing was contrary to the
provisions of Section 503 (b) (1), and resulted in the dispensed drugs being
misbranded while held for sale.
DISPOSITION: September 14, 1953. The defendant having entered a plea of
guilty, the court fined him $625, plus costs.